BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Prognosis
48 results:

  • 1. Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative breast cancer by Integrated Bioinformatical Analysis.
    Han YH; Wang Y; Lee SJ; Mao YY; Jiang P; Sun HN; Jin MH; Kwon T
    Anticancer Res; 2023 Jul; 43(7):2951-2964. PubMed ID: 37351977
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives.
    Lother D; Robert M; Elwood E; Smith S; Tunariu N; Johnston SRD; Parton M; Bhaludin B; Millard T; Downey K; Sharma B
    Cancer Imaging; 2023 May; 23(1):53. PubMed ID: 37254225
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. HORMONE-RECEPTOR -POSITIVE breast cancer: DIFFERENT prognosis OF BONE METASTASIS AMONG MOLECULAR SUBTYPES.
    Tevzadze M; Kakhadze S; Baramia M; Rukhadze T; Khatashvili Z; Mirzaey S
    Georgian Med News; 2023 Mar; (336):54-58. PubMed ID: 37166880
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC).
    Kataoka A; Ueno T; Yamauchi H; Uehiro N; Takahata C; Takahashi Y; Nakashima E; Ogiya A; Sakai T; Kitagawa D; Morizono H; Miyagi Y; Iwase T; Kitano A; Fukatsu Y; Tamura N; Kawano J; Bando H; Tamaki K; Shiota K; Ozawa M; Kobayashi M; Ohno S
    Breast Cancer; 2022 Sep; 29(5):825-834. PubMed ID: 35604614
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP).
    Cao W; Liu X; Su W; Liang H; Tang H; Zhang W; Huang S; Dang N; Qiao A
    Bioengineered; 2022 Feb; 13(2):4573-4586. PubMed ID: 35152838
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patients.
    Zou J; Gu Y; Zhu Q; Li X; Qin L
    Cancer Biomark; 2022; 34(3):393-401. PubMed ID: 35068448
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human breast cancer.
    Li F; Zhang Y; Shi Y; Liu S
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Low KIBRA Expression Is Associated with Poor prognosis in Patients with Triple-Negative breast cancer.
    Kim SW; Chu J; Do SI; Na K
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441043
    [No Abstract]    [Full Text] [Related]  

  • 9. Heart failure is associated with an increased incidence of cancer diagnoses.
    Roderburg C; Loosen SH; Jahn JK; Gänsbacher J; Luedde T; Kostev K; Luedde M
    ESC Heart Fail; 2021 Oct; 8(5):3628-3633. PubMed ID: 34180146
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis.
    Wang K; Jin X; Wang W; Yu X; Huang J
    BMC Cancer; 2021 Jun; 21(1):728. PubMed ID: 34172014
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
    Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
    Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
    BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Predicting the Incidence and prognosis of Bone Metastatic breast cancer: A SEER-Based Observational Study.
    Shi D; Bai J; Chen Y; Wang X; Zhang Y; Liu H
    Biomed Res Int; 2020; 2020():1068202. PubMed ID: 33294433
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1.
    André F; Ciruelos EM; Juric D; Loibl S; Campone M; Mayer IA; Rubovszky G; Yamashita T; Kaufman B; Lu YS; Inoue K; Pápai Z; Takahashi M; Ghaznawi F; Mills D; Kaper M; Miller M; Conte PF; Iwata H; Rugo HS
    Ann Oncol; 2021 Feb; 32(2):208-217. PubMed ID: 33246021
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Construction of a prognosis-predicting model based on autophagy-related genes for hepatocellular carcinoma (HCC) patients.
    Zhu Y; Wang R; Chen W; Chen Q; Zhou J
    Aging (Albany NY); 2020 Jul; 12(14):14582-14592. PubMed ID: 32681721
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Risk of Gynecologic cancer as Second versus First Primary cancer in Japan.
    Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
    Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. breast cancer Recurrence in the Nipple-Areola Complex After Nipple-Sparing Mastectomy With Immediate breast Reconstruction for Invasive breast cancer.
    Wu ZY; Kim HJ; Lee JW; Chung IY; Kim JS; Lee SB; Son BH; Eom JS; Kim SB; Gong GY; Kim HH; Ahn SH; Ko B
    JAMA Surg; 2019 Nov; 154(11):1030-1037. PubMed ID: 31461141
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Role of programmed cell death ligand-1 expression on prognostic and overall survival of breast cancer: A systematic review and meta-analysis.
    Li S; Chen L; Jiang J
    Medicine (Baltimore); 2019 Apr; 98(16):e15201. PubMed ID: 31008945
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.
    Falstie-Jensen AM; Kjærsgaard A; Lorenzen EL; Jensen JD; Reinertsen KV; Dekkers OM; Ewertz M; Cronin-Fenton DP
    Breast Cancer Res; 2019 Mar; 21(1):44. PubMed ID: 30902106
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. T Cell Immunoglobulin- and Mucin-Domain-Containing Molecule 3 Gene Polymorphisms and Susceptibility to Invasive breast cancer.
    Cheng S; Ju Y; Han F; Wang Y; Xu Y; Qu T; Lu Z
    Ann Clin Lab Sci; 2017 Nov; 47(6):668-675. PubMed ID: 29263040
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.